Navigation Links
Anavex comments on failure of Pfizer and Medivation's Alzheimer's investigational drug Dimebon during Phase 3 clinical trials
Date:3/3/2010

ANAVEX's SIGMACEPTOR(TM)-N program involves the development of novel and original drug candidates that target neurological and neurodegenerative diseases (Alzheimer's disease, epilepsy, depression, pain). The company's lead drug candidates exhibit high, non-exclusive affinity for sigma receptors, which have been extensively documented as potentially valuable drug targets and have demonstrated evidence for anti-amnesic and neuroprotective properties. The company is developing non-amyloid focused approaches to disease modification in Alzheimer's disease. ANAVEX 1-41 and ANAVEX 2-73 modulate sigma receptors, a unique class of receptor molecules, to guard against oxidative stress and work through alternative mitochondrial pathways via ion channel signalling. So far the compounds have performed extremely well in well-recognized animal models of Alzheimer's disease, underscoring the promise of the company's new alternative approach to the disease.

ANAVEX's SIGMACEPTOR(TM)-C program involves the development of novel and original drug candidates targeting cancer. The company's lead drug candidates exhibit high, non-exclusive affinity for sigma receptors with strong evidence for selective pro-apoptotic, anti-metastatic and low toxicity properties in various types of solid cancers. ANAVEX 7-1037 has already demonstrated its ability to significantly delay the growth of cancerous tumors in patient-derived xenografts during advanced pre-clinical studies.


'/>"/>
SOURCE Anavex Life Sciences Corp.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Anavex appoints Dr. Dimitri Goundis to lead Clinical Development
2. Anavex 7-1037 reduces rate of cancer tumor growth 69% in pre-clinical studies, compared to currently marketed drug Dacarbazine showing no measurable activity
3. Anavex strengthens Board of Directors
4. Anavex advances drug candidate for treatment of Alzheimers disease
5. American Medical Informatics Association (AMIA) Submits Comments to Hit Policy Committee About Meaningful Use and Electronic Health Record Certification
6. Amylin Comments on RiskMetrics Report
7. The Society of Forensic Toxicologists Comments on the National Academy of Sciences Report on Strengthening Forensic Science in the United States
8. American Oriental Bioengineering Comments on Recent Property Purchase
9. Boston Scientific Provides Comments Reinforcing Strength of Its Balance Sheet
10. Dietitian Mary Lee Chin Comments on Proven Value and Safety of Food Biotechnology in New Online Video
11. KV Pharmaceutical Company Comments on Legal Development in Its Branded Pharmaceutical Business
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... 2015  scPharmaceuticals, Inc., a privately held ... subcutaneous delivery, announced today that it has ... proprietary drug product, Furosemide Injection Solution, for ... heart failure. Concurrently with its ... patch pump.  The patch pump is designed ...
(Date:4/21/2015)... RESEARCH TRIANGLE PARK, N.C. , April 21, ... ) announced today that it will release its first ... April 28, 2015. United Therapeutics will host ... 9:00 a.m. Eastern Time.  The teleconference is accessible by ... of the teleconference will be available for one week ...
(Date:4/21/2015)... (PRWEB) April 21, 2015 A leading ... AMERICA is slated to discuss its custom fabrication services ... its reimagined website, which launched just prior to the ... Thurs. (April 21, 22 and 23) at the Javits ... representatives of the world’s largest and most innovative pharmaceutical ...
(Date:4/20/2015)... Stent retriever thrombectomy, an endovascular technique ... brain reduced disability after stroke, according to a ... of the Society of Vascular and Interventional Neurology ... step forward that will change the way we ... Jovin, who is associate professor of Neurology and ...
Breaking Biology Technology:scPharmaceuticals Announces Start of Pivotal Trial for Novel Furosemide Solution for Subcutaneous Delivery 2scPharmaceuticals Announces Start of Pivotal Trial for Novel Furosemide Solution for Subcutaneous Delivery 3HOLLOWAY AMERICA to Reveal Newly Designed Responsive Website at INTERPHEX 2015 Today 2HOLLOWAY AMERICA to Reveal Newly Designed Responsive Website at INTERPHEX 2015 Today 3SVIN President Tudor Jovin, MD, Co-Leads Groundbreaking Stroke Study In The New England Journal Of Medicine 2SVIN President Tudor Jovin, MD, Co-Leads Groundbreaking Stroke Study In The New England Journal Of Medicine 3
... San Francisco or Boston, and youre on the verge of investing ... right: The management team is in place, the business plan is ... a lawyer steps into the room, clears her throat and asks ... not write that check, she says, until you learn more about ...
... Inc. has received a written notification from the ... file financial reports for the quarter ending March 31, 2006 ... stock from NASDAQ. , ,Representatives of Merge, which does ... Qualifications Panel to request that the panel grant Merge an ...
... - Who needs a record label? Independent musicians can now ... and sell it five minutes later, courtesy of a new ... technology firm's Web Hosting 2.0 represents a customization expansion over ... users to host their existing Web site with Broadjam, or ...
Cached Biology Technology:Why repealing the shareholder wage lien law makes sense 2Why repealing the shareholder wage lien law makes sense 3
(Date:4/21/2015)... High crime rate, increasing ... access control systems market in Saudi Arabia ... published report by TechSci Research " Saudi Arabia Access Control ... systems market in Saudi Arabia ... control systems market in the Kingdom is growing at ...
(Date:4/20/2015)... 2015 Huntington Memorial Hospital is the first ... new miniaturized, wireless monitoring sensor to manage heart failure ... only FDA-approved heart failure monitoring device that has been ... physicians to manage heart failure. The CardioMEMS ... the pulmonary artery (PA) during a non-surgical procedure to ...
(Date:4/20/2015)... The announcement comes as demand ... Management (GRM), Ireland,s foremost records management ... built up an impressive track record of clients within the ... the records management sector in Dubai . ... staffbase and employ a further eight staff members at its ...
Breaking Biology News(10 mins):Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 2Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 3Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 2Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 3
... , April 23, 2010 , Carlos Moreira , Chairman and Founder ... address to a selected audience of over 500,entrepreneurs and members of the science ... week-end in Cambridge,Massachusetts . , , ... Carlos Moreira will debate some of these initiatives ...
... Molecular biologist Alan Ashworth, Ph.D., FRS, the director of ... Cancer Research in London will receive the David T. Workman ... $50,000 from the Samuel Waxman Cancer Research Foundation will support ... "I,m both surprised and delighted that the Waxman Foundation has ...
... been working for more than a decade to understand ... Now researchers have discovered that microRNA actually moves between ... ultimately determine the types of cells that grow and ... wide range of fields, including medical gene therapy and ...
Cached Biology News:WISeKey Announce New Services and Solutions for Latin America at MIT 2WISeKey Announce New Services and Solutions for Latin America at MIT 3Alan Ashworth to receive award for his breakthrough work in breast cancer 2Production of biofuels could benefit by controlling the types of cells that develop in plants 2
Mouse monoclonal antibody to PDK2 - pyruvate dehydrogenase kinase, isoenzyme 2...
... selection system for recombinant identification. Recombinant selection ... need for costly color screening. This quick ... accuracy in recombinant selection. pLivSelect is also ... This cloning kit can be used for ...
Mouse monoclonal to Casein Kinase 2 beta ( Abpromise for all tested applications). entrezGeneID: 1460 SwissProtID: P13862...
Alpha-2-antiplasmin precursor (Alpha-2-plasmin inhibitor) (Alpha-2-PI) (Alpha-2-AP). [Source:Uniprot/SWISSPROT;Acc:P08697] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Biology Products: